• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

Frequent Blood Donation Does Not Increase Clonal Hematopoiesis

March 19, 2025

Each whole blood donation stimulates erythropoiesis by 2.5% to 4% to replace lost cells. Since male blood donors can donate up to six times per year, increased levels of erythropoietin may represent a novel selection pressure on hematopoietic stem cells (HSCs). To determine if frequent, repeated whole blood donations favor certain mutations in HSCs or increase clonal hematopoiesis, researchers analyzed two age- and health-matched cohorts of males over 60 years of age. One cohort included 217 males with over 100 whole blood donations, while the other included 212 males with less than ten donations. No significant difference in the overall incidence of clonal hematopoiesis was found between the two cohorts. The most prevalent mutations were observed in the DNMT3A and TET2 genes, which are commonly affected in clonal hematopoiesis. Distinct patterns of genetic mutations, however, were observed in both cohorts. Based on CRISPR/Cas9 mutated human HSCs in cultures, mutations observed in frequent donors expand when exposed to erythropoietin but not inflammatory stimuli (unlike pre-leukemia mutations which expand when exposed to inflammatory stimuli). Further research is needed to assess the effects of frequent blood donation on HSCs.

Reference:

Karpova D, Encabo HH, Donato E, Calderazzo S, et al. Clonal Hematopoiesis Landscape in Frequent Blood Donors. Blood 2025; blood.2024027999.

Filed Under

  • Blood Donation
  • News

Recommended

  • VIDEO: Blood Donor Lead Levels and Concern for Infants and Children

  • Potential Screening for Cytomegalovirus among Cord Blood Donors

  • Immune Plasma: A Promising Therapy to Treat Influenza

Show Comments

Comments on this article are closed.

Get the latest news. Subscribe to our mailing list. Sign Up

Primary Sidebar

Latest News

  • Influence of Transfusion Recipient and Donor Traits in Patients with Sickle Cell Disease

  • Pre-Hospital Resuscitation with Low-Titer Type O Whole Blood for Trauma Patients

  • Double-knotting Blood Storage Bag Tubing Reduces Contamination

  • Costs of Type & Screen and Crossmatch Laboratory Tests for RBCs Higher in U.S. Compared to U.K.

    Question of the Day

    Copyright © 2026 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley